Dalcetrapib 5 mg | 97.99%
TargetMol
Dalcetrapib, a rhCETP inhibitor (IC50=0.2 μM), increases the plasma HDL cholesterol.
More Information Supplier PageDalcetrapib
Search Results
Dalcetrapib 10 mg | 97.99%
TargetMol
Dalcetrapib, a rhCETP inhibitor (IC50=0.2 μM), increases the plasma HDL cholesterol.
More Information Supplier PageDalcetrapib
Succinobucol 5 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
Succinobucol 50 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
Succinobucol 25 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
Succinobucol 10 mg | 98.80%
TargetMol
Succinobucol is a novel phenolic antioxidant small molecule with anti-oxidant and anti-inflammatory properties. It designed to treat atherosclerosis of the blood vessels of the heart or coronary artery disease.
More Information Supplier PageSuccinobucol
VCMMAE 5 mg | 99.58%
TargetMol
VcMMAE is a drug-linker conjugate for ADC with potent antitumor activity.
More Information Supplier PageVCMMAE
Skepinone-L 10 mg | 99.76%
TargetMol
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L
Skepinone-L 25 mg | 99.76%
TargetMol
Skepinone-L is a selective p38 mitogen-activated protein kinase inhibitor.
More Information Supplier PageSkepinone-L
MRS 2578 25 mg | Purity Not Available
TargetMol
MRS2578, an effective P2Y6 receptor antagonist with IC50 of 37 nM, shows insignificant inhibition at P2Y1, P2Y2, P2Y4, and P2Y11 receptors.
More Information Supplier PageMRS 2578
